Clinical Trial

MYTHS - MYocarditis THerapy With Steroids

Study acronym: MYTHS
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This is a phase III, multi-center international, single blind randomized controlled trial to test the efficacy of pulsed intravenous (IV) methylprednisolone versus standard therapy on top of maximal support in patients with Acute myocarditis (AM).
Protocol Amendment History 14 amendments
This ClinicalTrials.gov record has been amended 14 times since 2021-11-26; most recent amendment 2025-07-30.
Trial Details
NCT Number NCT05150704
Lead Sponsor Niguarda Hospital
Collaborators: Ministry of Health, Italy, Istituto Di Ricerche Farmacologiche Mario Negri, University of Milano Bicocca, Regione Lombardia
Conditions Myocarditis Acute
Enrollment 288 participants
Start Date 2021-10-07
Primary Completion 2028-03 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2025-07-31